ArticleCancer immunology, immunotherapy : CII2015

Intravesical chitosan/interleukin-12 immunotherapy induces tumor-specific systemic immunity against murine bladder cancer.

Sean G Smith et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.